Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Current Assets (2020 - 2024)

Immuneering (IMRX) has 5 years of Current Assets data on record, last reported at $55.3 million in Q3 2024.

  • For Q3 2024, Current Assets fell 45.06% year-over-year to $55.3 million; the TTM value through Sep 2024 reached $55.3 million, down 45.06%, while the annual FY2023 figure was $89.1 million, 18.08% down from the prior year.
  • Current Assets reached $55.3 million in Q3 2024 per IMRX's latest filing, down from $63.7 million in the prior quarter.
  • Across five years, Current Assets topped out at $153.3 million in Q3 2021 and bottomed at $37.7 million in Q4 2020.
  • Average Current Assets over 5 years is $98.7 million, with a median of $100.6 million recorded in 2023.
  • Peak YoY movement for Current Assets: soared 303.73% in 2021, then tumbled 45.06% in 2024.
  • A 5-year view of Current Assets shows it stood at $37.7 million in 2020, then soared by 303.73% to $152.3 million in 2021, then decreased by 28.61% to $108.7 million in 2022, then fell by 18.08% to $89.1 million in 2023, then plummeted by 37.97% to $55.3 million in 2024.
  • Per Business Quant database, its latest 3 readings for Current Assets were $55.3 million in Q3 2024, $63.7 million in Q2 2024, and $74.4 million in Q1 2024.